Artificial intelligence links CT images to pathologic features and survival outcomes of renal masses.
Published version
Peer-reviewed
Repository URI
Repository DOI
Type
Change log
Abstract
Treatment decisions for an incidental renal mass are mostly made with pathologic uncertainty. Improving the diagnosis of benign renal masses and distinguishing aggressive cancers from indolent ones is key to better treatment selection. We analyze 13261 pre-operative computed computed tomography (CT) volumes of 4557 patients. Two multi-phase convolutional neural networks are developed to predict the malignancy and aggressiveness of renal masses. The first diagnostic model designed to predict the malignancy of renal masses achieves area under the curve (AUC) of 0.871 in the prospective test set. This model surpasses the average performance of seven seasoned radiologists. The second diagnostic model differentiating aggressive from indolent tumors has AUC of 0.783 in the prospective test set. Both models outperform corresponding radiomics models and the nephrometry score nomogram. Here we show that the deep learning models can non-invasively predict the likelihood of malignant and aggressive pathology of a renal mass based on preoperative multi-phase CT images.
Description
Acknowledgements: This study was funded by grants from National Natural Science Foundation of China [81902563 (Y.X.), 81974393 (J.G.), 82102967 (Y.Q.), 82202106 (C.D.), Outstanding Youth Scholars Foundation of Zhongshan Hospital [2021ZSYQ15 (Y.X.)], Science and Technology Guided Project of Fujian Province [2019D025 (J.Z.)], Scientific Research Cultivation and Medical Innovation Project of Fujian Province [2019CXB33 (J.Z.)], Hexi University President Fund Innovation Team Project [CXTD2022012 (J.Y.)], Funding Program for Young Research Projects in the Scientific and Technological Plan for High-quality Development of Health in Xiamen[2024GZL-QN027 (J.L.)], Natural Science Foundation of Fujian Province [2024J011442 (C.D.)], International Science and Technology Cooperation Program under the 2023 Shanghai Action Plan for Science [(23410710400) (S.W.)], and Shanghai Sailing Programs of Shanghai Municipal Science and Technology Committee [22YF1409300 (S.W.)]. All these study sponsors have no roles in the study design, in the collection, analysis and interpretation of data. We would like to thank Dr. Jianming Zeng (University of Macau) and all the members of his bioinformatics team for their generous help in bioinformatics analysis. We thank pathologists Qi Sun (Fudan University) and Haiyue Lin (the First People’s Hospital of Lianyungang) for re-evaluating pathologic slides. We thank radiologist Xiaoxia Li (Fudan University) for assessing tumor malignancy and R.E.N.A.L. score. The computations in this research were performed using the CFFF platform of Fudan University.
Journal Title
Conference Name
Journal ISSN
2041-1723